Penny Stock Under Rs 50: Take Solutions Hits Back-to-Back 2% Upper Circuits; Announces Entry into Longevity and Anti-Ageing Market

Penny Stock Under Rs 50: Take Solutions Hits Back-to-Back 2% Upper Circuits; Announces Entry into Longevity and Anti-Ageing Market

Take Solutions enters India’s longevity and anti-ageing market with science-backed nutraceuticals and digital preventive health tools.

AI Powered Summary

On Friday, Indian markets traded on a positive note, with the Nifty 50 rising 0.47 per cent to 24,310.25, up 113.50 points from the previous close of 24,196.75. Amid this, Take Solutions share price was trading at Rs 49.16, up 1.99 per cent from the previous close of Rs 48.20, following the company’s announcement of its strategic entry into the longevity and anti-ageing solutions segment.

Every portfolio needs a growth engine. DSIJ’s Flash News Investment (FNI) provides weekly stock market insights and recommendations, tailored for both short-term traders and long-term investors. Download PDF Service Note Here

Take Solutions Enters Longevity and Anti-Ageing Market

Take Solutions Ltd has announced plans to enter the longevity and anti-ageing market, focusing on developing science-backed nutraceuticals, biohacking solutions, and technology-enabled preventive healthcare offerings. The company aims to leverage its expertise in clinical research, life sciences, and regulatory processes to build a scalable platform across consumer health products and digital wellness solutions.

Market Opportunity and Growth Outlook

The global longevity market was valued at USD 27.61 billion in 2025 and is projected to reach USD 67.03 billion by 2035, growing at a CAGR of 9.41 per cent.

In India, opportunities are expanding across preventive healthcare and anti-ageing segments. The preventive healthcare market was valued at USD 197 billion, while the anti-ageing supplements market is expected to grow from USD 168.6 million in 2025 to USD 341.4 million by 2033. The anti-ageing services market, valued at USD 567.5 million in 2024, is projected to reach USD 1,059.6 million by 2035, reflecting steady growth in the segment.

Strategy and Business Model

The company’s strategy is based on a dual model combining product innovation with technology-enabled healthcare solutions. It plans to develop nutraceuticals, biohacking-focused products, and predictive digital tools aimed at monitoring and improving metabolic health, sleep, cognition, and biological ageing.

Management Commentary

Commenting on the development, Mr Parmeshvar Dhangare, Director of Take Solutions Limited, said: “Through this initiative, we aim to build a diversified revenue mix across consumer products, services, and digital platforms, while leveraging our core strengths in healthcare and regulatory execution to deliver solutions that are both scalable and clinically credible.”

About Take Solutions

Take Solutions Ltd is a technology-driven company focused on life sciences and healthcare solutions. It provides clinical, regulatory, and safety services supported by analytics and digital platforms to global pharmaceutical, biotech, and medical device companies.

The company is also expanding its presence in digital health and preventive healthcare, aligning with evolving industry trends and increasing demand for personalised and technology-enabled healthcare solutions.

Add DSIJ as your preferred news source on G o o g l e

Add Now

Share your views in the comments below.
Disclaimer: This article is for informational purposes only and not investment advice.